InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System
MIAMI, Oct. 15, 2024 ( GLOBE NEWSWIRE ) -- InspireMD, Inc. ( Nasdaq: NSPR ) , developer of the CGuard™ Embolic Prevention Stent System ( EPS ) for the prevention of stroke, today announced the establishment of its global headquarters in Miami, Florida.
| Ticker |
Sentiment |
Impact |
|
CURN
|
Neutral
|
4 %
|
|
NSPR
|
Neutral
|
25 %
|
